GE HealthCare Technologies Inc.
GEHC
Rang in aandelen
#773
GE HealthCare Technologies Inc. is a global medical technology company that... GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
Aandeelprijs
$69.86
Laatst gesynchroniseerd: 2026-10-20
Marktkapitalisatie
$31.56B
Verandering (1 dag)
0.15%
Verandering (1 jaar)
-8.19%
Land
US
Handel GE HealthCare Technologies Inc. (GEHC)
Categorie
Healthcare
Winst voor GE HealthCare Technologies Inc. (GEHC)
Winst in Jun 2026 TTM: $2.04B
Volgens de meest recente financiële verslagen van GE HealthCare Technologies Inc. bedraagt de huidige winst van het bedrijf $2.04B. In 2024 behaalde het bedrijf een winst van $2.58B, een stijging ten opzichte van de winst van 2023, die $2.36B bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van GE HealthCare Technologies Inc. van 2019 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $2.04B | -26.19% |
| 2025 | $2.77B | 7.25% |
| 2024 | $2.58B | 9.32% |
| 2023 | $2.36B | -6.01% |
| 2022 | $2.51B | -12.63% |
| 2021 | $2.88B | 6.09% |
| 2020 | $2.71B | 29.60% |
| 2019 | $2.09B | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $266.26M | -86.97% |
AU
|
|
| $295.53M | -85.53% |
US
|
|
| $-259.89M | -112.72% |
US
|
|
| $-74.89M | -103.67% |
US
|
|
| - | - |
US
|
